Clinical trial
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin…
NCT00360074 · University Hospital Freiburg, Other · Completed
Key facts
| NCT number | NCT00360074 |
|---|---|
| Title | Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation |
| Official title | A Randomised, Controlled, Crossover Study: Treatment With Thyroxin Compared to Thyroxin + Triiodothyronin in Patients With Secondary Hypothyroidism |
| Lead sponsor | University Hospital Freiburg, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hypothyroidism, Hypopituitarism, Hyperlipidemias |
| Intervention type | Drug |
| Interventions | Thyroxin, Triiodothyronine |
| Enrollment | 25 |
| Start date | Feb 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Aug 3, 2006 |
| Last update posted | Jun 9, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: